News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
689,641 Results
Type
Article (64793)
Company Profile (195)
Press Release (624653)
Section
Business (188056)
Career Advice (2857)
Deals (35063)
Drug Delivery (102)
Drug Development (81404)
Employer Resources (170)
FDA (16108)
Job Trends (15139)
News (329728)
Policy (32441)
Tag
Academia (2919)
Alliances (47566)
Alzheimer's disease (1256)
Approvals (16036)
Artificial intelligence (157)
Bankruptcy (322)
Best Places to Work (11756)
Biotechnology (156)
Breast cancer (193)
Cancer (1365)
Cardiovascular disease (113)
Career advice (2423)
Cell therapy (289)
Clinical research (64878)
Collaboration (451)
Compensation (205)
COVID-19 (2659)
C-suite (118)
Data (1378)
Diabetes (165)
Diagnostics (6325)
Drug pricing (100)
Earnings (65878)
Employer resources (150)
Events (103620)
Executive appointments (381)
FDA (16760)
Funding (419)
Gene therapy (198)
GLP-1 (603)
Government (4677)
Healthcare (19340)
Infectious disease (2743)
Inflammatory bowel disease (115)
Interviews (532)
IPO (16030)
Job creations (3773)
Job search strategy (2045)
Layoffs (461)
Legal (7638)
Lung cancer (197)
Manufacturing (193)
Medical device (13324)
Medtech (13329)
Mergers & acquisitions (19198)
Metabolic disorders (427)
Neuroscience (1574)
NextGen Class of 2024 (6884)
Non-profit (4682)
Northern California (1571)
Obesity (236)
Opinion (219)
Patents (116)
People (60224)
Phase I (20223)
Phase II (28481)
Phase III (21159)
Pipeline (495)
Postmarket research (2717)
Preclinical (8680)
Radiopharmaceuticals (247)
Rare diseases (264)
Real estate (6340)
Regulatory (21571)
Research institute (2483)
Resumes & cover letters (429)
Southern California (1375)
Startups (3599)
United States (14329)
Vaccines (591)
Weight loss (170)
Date
Last 7 days (690)
Last 30 days (2379)
Last 365 days (34733)
2024 (33950)
2023 (39313)
2022 (50411)
2021 (55425)
2020 (54247)
2019 (47954)
2018 (36487)
2017 (33066)
2016 (32679)
2015 (38186)
2014 (31081)
2013 (27487)
2012 (28898)
2011 (29188)
2010 (27660)
Location
Africa (938)
Arizona (150)
Asia (41030)
Australia (7446)
California (3532)
Canada (1366)
China (286)
Colorado (164)
Connecticut (176)
Europe (94346)
Florida (504)
Georgia (129)
Illinois (410)
Indiana (217)
Maryland (598)
Massachusetts (2719)
Michigan (175)
Minnesota (257)
New Jersey (1049)
New York (1019)
North Carolina (784)
Northern California (1571)
Ohio (136)
Pennsylvania (843)
South America (1287)
Southern California (1375)
Texas (518)
Utah (106)
Washington State (387)
689,641 Results for "unit of biotechnology ben gurion university".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Business
Actio Biosciences Appoints Ben Cravatt, Ph.D., to Board of Directors
Actio Biosciences, a biotechnology company leveraging a novel platform approach to genetics and precision medicine to develop new therapeutics that target shared underlying biology in both rare and common diseases, today announced that Ben Cravatt, Ph.D., has joined the company’s board of directors.
May 22, 2024
·
2 min read
Press Releases
Evoke Pharma Announces the Appointment of Ben Smeal to the Board of Directors
October 23, 2024
·
4 min read
Business
Ben-Gurion University and Soroka Medical Center Announce Strategic Collaboration for Novel Technologies in the Field of Bio-Convergence
Ben-Gurion University of the Negev (BGU) and Soroka Medical Center announced a strategic collaboration for the development of novel technologies in the filed of Bio-Convergence (a field that combines biology with computational technologies and engineering).
May 4, 2022
·
7 min read
Deals
Sanofi Seals Deal With Private Equity Firm for 50% Stake in Consumer Healthcare Unit
Sanofi will sell a 50% controlling stake in consumer healthcare unit Opella to private equity firm CD&R, with the French government taking a stake as well to ensure the business remains in the county.
October 21, 2024
·
2 min read
·
Annalee Armstrong
Policy
Pushback Against IRA’s Controversial ‘Pill Penalty’ Faces Stiff Budgetary Headwinds
The EPIC Act has been proposed with bipartisan and industry support to give small molecule drugs the same protection against price negotiation as biologics, but concerns over how to balance the federal budget could prevent a short-term fix to the IRA.
December 11, 2024
·
5 min read
·
Ben Hargreaves
Drug Development
Ben-Gurion University Researchers to Develop Novel Biological Treatment for Inflammatory Bowel Diseases
Researchers at Ben-Gurion University of the Negev are developing a novel therapeutic strategy for treating Inflammatory Bowel Diseases by sequestering inflammation-inducing molecules secreted by gut bacteria.
August 11, 2021
·
4 min read
Deals
Telix Announces Launch of Proposed Initial Public Offering in the United States
Telix Pharmaceuticals Limited (the “Company” or “Telix”) today announces the launch of its initial public offering in the United States (the “Offering”) of 17,000,000 American Depositary Shares (“ADSs”), each representing one ordinary share in Telix.
June 5, 2024
·
6 min read
NewAmsterdam Pharma Announces Issuance of Composition of Matter Patent for Obicetrapib by the United States Patent and Trademark Office
NewAmsterdam Pharma Company N.V. (Nasdaq: NAMS or “NewAmsterdam” or the “Company”) today announced that the United States Patent and Trademark Office (“USPTO”) has issued U.S. Patent No. 12,006,305, titled “Salts of Obicetrapib and Processes for their Manufacture and Intermediates Thereof.”
June 11, 2024
·
7 min read
Press Releases
Commencement of trading on OTCQB in the United States
October 8, 2024
·
3 min read
Press Releases
PharmaDrug Announces Issuance of Debenture Units
November 15, 2024
·
5 min read
1 of 68,965
Next
